7.5024
Schlusskurs vom Vortag:
$7.51
Offen:
$7.42
24-Stunden-Volumen:
721.05K
Relative Volume:
0.56
Marktkapitalisierung:
$713.61M
Einnahmen:
$47.56M
Nettoeinkommen (Verlust:
$-156.83M
KGV:
-4.0997
EPS:
-1.83
Netto-Cashflow:
$-127.98M
1W Leistung:
-8.08%
1M Leistung:
-5.06%
6M Leistung:
-42.50%
1J Leistung:
-54.24%
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Firmenname
Avadel Pharmaceuticals Plc
Sektor
Telefon
636-449-1830
Adresse
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Vergleichen Sie AVDL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AVDL
Avadel Pharmaceuticals Plc
|
7.495 | 713.61M | 47.56M | -156.83M | -127.98M | -1.83 |
![]()
ZTS
Zoetis Inc
|
163.26 | 72.50B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.96 | 47.08B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
10.15 | 45.99B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.32 | 17.38B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ITCI
Intra Cellular Therapies Inc
|
131.87 | 14.05B | 612.78M | -86.37M | -62.91M | -0.87 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
2024-06-12 | Eingeleitet | Rodman & Renshaw | Buy |
2024-03-05 | Bestätigt | H.C. Wainwright | Buy |
2024-03-05 | Bestätigt | Needham | Buy |
2024-03-05 | Bestätigt | Oppenheimer | Outperform |
2024-02-06 | Eingeleitet | UBS | Buy |
2022-11-30 | Hochstufung | Jefferies | Hold → Buy |
2022-08-10 | Herabstufung | Jefferies | Buy → Hold |
2022-07-28 | Fortgesetzt | Craig Hallum | Buy |
2022-05-26 | Herabstufung | Stifel | Buy → Hold |
2021-09-23 | Eingeleitet | Needham | Buy |
2020-07-31 | Eingeleitet | Oppenheimer | Outperform |
2020-07-21 | Eingeleitet | SVB Leerink | Outperform |
2020-06-30 | Eingeleitet | H.C. Wainwright | Buy |
2020-04-03 | Eingeleitet | Jefferies | Buy |
2020-03-12 | Eingeleitet | Stifel | Buy |
2020-02-26 | Eingeleitet | Piper Sandler | Overweight |
2020-01-30 | Eingeleitet | Craig Hallum | Buy |
2019-06-14 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
2019-02-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
Alle ansehen
Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten
Teacher Retirement System of Texas Increases Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference - The Manila Times
When (AVDL) Moves Investors should Listen - news.stocktradersdaily.com
Charles Schwab Investment Management Inc. Raises Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Swiss National Bank Increases Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals Announces Publication of Manuscripts on Narcolepsy Management in CNS Drugs Supplement - Nasdaq
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians - The Manila Times
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with - EIN News
Atria Investments Inc Has $281,000 Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals at UBS Virtual CNS Day: Strategic Growth Insights By Investing.com - Investing.com UK
Bullish Avadel Pharmaceuticals Insiders Loaded Up On US$761.7k Of Stock - simplywall.st
Arizona State Retirement System Acquires 2,938 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals at Leerink Conference: Strategic Growth Plans By Investing.com - Investing.com South Africa
Insider Trading At Avadel Pharmaceuticals plc (NASDAQ: AVDL): What Did We Note? - Stocks Register
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Average Rating of “Buy” from Analysts - Defense World
Analyzing Avadel Pharmaceuticals plc (AVDL) After Recent Trading Activity - Knox Daily
HC Wainwright Issues Pessimistic Outlook for AVDL Earnings - Defense World
Avadel Pharmaceuticals Announces Executive Equity Grants By Investing.com - Investing.com South Africa
Avadel Pharmaceuticals Announces Executive Equity Grants - Investing.com
Avadel Pharmaceuticals Plc to Host Earnings Call - ACCESS Newswire
Avadel Pharmaceuticals PLC Sponsored ADR to Host Earnings Call - ACCESS Newswire
What is HC Wainwright’s Forecast for AVDL Q3 Earnings? - Defense World
What is Lifesci Capital’s Forecast for AVDL Q2 Earnings? - Defense World
Oppenheimer & Co. Inc. Boosts Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - MarketBeat
Sanctuary Advisors LLC Takes Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Rhumbline Advisers Increases Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
What is Lifesci Capital’s Estimate for AVDL Q1 Earnings? - Defense World
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences - The Manila Times
New York State Common Retirement Fund Sells 389,555 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals (NASDAQ:AVDL) Given “Buy” Rating at HC Wainwright - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2024 Earnings Call Transcript - MSN
Deutsche Bank Adjusts Avadel Pharmaceuticals Price Target to $13 From $12, Maintains Buy Rating - Marketscreener.com
Avadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from Needham & Company LLC - Defense World
Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Avadel Pharmaceuticals Reports Strong Growth in 2024 - TipRanks
Oppenheimer maintains Avadel Outperform rating, $22 target By Investing.com - Investing.com UK
Earnings call transcript: Avadel Pharmaceuticals Q4 2024 reveals revenue miss - Investing.com India
Avadel Pharma earnings missed by $0.03, revenue fell short of estimates - Investing.com Australia
Avadel Pharmaceuticals PLC reports results for the quarter ended December 31Earnings Summary - TradingView
AVADEL PHARMACEUTICALS PLC SEC 10-K Report - TradingView
Avadel: Q4 Earnings Snapshot - CTPost
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Avadel Pharmaceuticals Reiterates 2025 Guidance -March 03, 2025 at 07:16 am EST - Marketscreener.com
Is Avadel Pharmaceuticals plc (AVDL) the Best Small Cap Pharma Stocks to Buy Now? - Insider Monkey
Avadel Pharmaceuticals (AVDL) Expected to Announce Earnings on Monday - Defense World
Avadel Pharmaceuticals PLC expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3 - The Manila Times
Finanzdaten der Avadel Pharmaceuticals Plc-Aktie (AVDL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Avadel Pharmaceuticals Plc-Aktie (AVDL) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Thornton Peter J. | Director |
Jan 13 '25 |
Buy |
8.04 |
10,000 |
80,450 |
104,055 |
Ende Eric J | Director |
Jan 13 '25 |
Buy |
7.84 |
30,000 |
235,218 |
208,900 |
MCHUGH THOMAS S | Chief Financial Officer |
Dec 13 '24 |
Buy |
10.44 |
2,300 |
24,019 |
87,800 |
MCHUGH THOMAS S | Chief Financial Officer |
Dec 11 '24 |
Buy |
10.49 |
5,000 |
52,432 |
85,500 |
Divis Gregory J | Chief Executive Officer |
Dec 06 '24 |
Buy |
9.98 |
9,598 |
95,759 |
9,598 |
Divis Gregory J | Chief Executive Officer |
Dec 09 '24 |
Buy |
9.82 |
402 |
3,948 |
10,000 |
Glass Geoffrey Michael | Director |
Dec 10 '24 |
Buy |
9.84 |
20,279 |
199,641 |
75,904 |
Palczuk Linda | Director |
Dec 06 '24 |
Buy |
10.19 |
3,000 |
30,568 |
66,400 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):